|
ABSI
|
Absci Corporation
|
US
|
NASDAQ
|
|
ADPT
|
Adaptive Biotechnologies Corporation
|
US
|
NASDAQ
|
|
ATHX
|
Athersys, Inc.
|
US
|
NASDAQ
|
|
BBC
|
Virtus LifeSci Biotech Clinical Trials ETF
|
US
|
AMEX
|
|
BCEL
|
Atreca, Inc.
|
US
|
NASDAQ
|
|
BLFS
|
BioLife Solutions, Inc.
|
US
|
NASDAQ
|
|
BLRX
|
BioLineRx Ltd.
|
US
|
NASDAQ
|
|
BMRN
|
BioMarin Pharmaceutical Inc.
|
US
|
NASDAQ
|
|
BNTX
|
BioNTech SE
|
US
|
NASDAQ
|
|
CERT
|
Certara, Inc.
|
US
|
NASDAQ
|
|
CLVS
|
Clovis Oncology, Inc.
|
US
|
NASDAQ
|
|
CMPS
|
COMPASS Pathways Plc
|
US
|
NASDAQ
|
|
CRIS
|
Curis, Inc.
|
US
|
NASDAQ
|
|
CRL
|
Charles River Laboratories International, Inc.
|
US
|
NYSE
|
|
CTKB
|
Cytek Biosciences, Inc.
|
US
|
NASDAQ
|
|
EVO
|
Evotec SE
|
US
|
NASDAQ
|
|
GE
|
General Electric Company
|
US
|
NYSE
|
|
GLUE
|
Monte Rosa Therapeutics, Inc.
|
US
|
NASDAQ
|
|
GLW
|
Corning Incorporated
|
US
|
NYSE
|
|
GLYC
|
GlycoMimetics, Inc.
|
US
|
NASDAQ
|